Lifeward

LFWD · NASDAQ

$6.06+$0.2431 (+4.18%)TodayMarket closed ·
Prev close $5.82

Latest news

  • Press releaseGlobe Newswire

    Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study

  • Press releaseGlobe Newswire

    Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain

  • Press releaseGlobe Newswire

    Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy

  • Press releaseGlobe Newswire

    Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer

  • Press releaseGlobe Newswire

    Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth

  • Press releaseGlobe Newswire

    Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026

  • Press releaseGlobe Newswire

    Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

  • Press releaseGlobe Newswire

    Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

  • Press releasePRNewswire

    Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

  • Press releaseGlobe Newswire

    Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

  • News

    Lifeward Q1 2026 Earnings Call Transcript

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    Lifeward Reports First Quarter 2026 Financial Results

  • News

    Earnings Scheduled For May 15, 2026

  • Press releaseGlobe Newswire

    Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026

  • News

    Earnings Scheduled For March 18, 2026

  • Press releaseGlobe Newswire

    Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

  • Press releaseGlobe Newswire

    Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

  • Press releasePRNewswire

    Oramed and Lifeward Announce Strategic Transaction

  • Press releaseGlobe Newswire

    Lifeward Ltd. Reports Third Quarter 2025 Financial Results

  • News

    Earnings Scheduled For November 14, 2025

  • News

    A Look Ahead: Lifeward's Earnings Forecast

  • News

    Preview: Rewalk Robotics's Earnings

  • Press releasePRNewswire

    MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

  • NewsAvi Kapoor

    Crude Oil Rises Sharply; Torrid Holdings Shares Plunge

  • NewsAvi Kapoor

    US Stocks Mixed; General Mills Shares Fall After Q4 Results

  • NewsAvi Kapoor

    Crude Oil Falls 1%; Dollar General Posts Upbeat Sales

  • NewsDylan Berman

    What's Going On With Lifeward Shares Thursday?

  • NewsAvi Kapoor

    Nasdaq Down Over 100 Points; US Producer Inflation Stalls In February

  • NewsThe Arora Report

    ChatGPT Moment For Robotics Is Around The Corner Says Nvidia CEO

  • NewsAvi Kapoor

    Nasdaq Down 1.5%; RPM Posts Upbeat Results

  • NewsAvi Kapoor

    Dow Surges Over 100 Points; US Trade Deficit Widens In November

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.